Glenmark gets USFDA nod to market skin cream
Glenmark says it has received ANDA approval from the US FDA for Ciclopirox Olamine Cream used in dermatological infections.
Mumbai: Drug company Glenmark Pharmaceuticals today said it has received ANDA approval from the US Food and Drug Administration (FDA) for Ciclopirox Olamine Cream used in dermatological infections.
The company has received the abbreviated new drug application (ANDA) approval from the US Food and Drug Administration for Ciclopirox Olamine Cream in 0.77 per cent strength, Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange.
Today``s approval augments Glenmark``s overall dermatological portfolio to 13 products, the filing added. Glenmark is currently authorised to distribute 50 products in the US market and has 46 pending ANDA approvals with the US FDA.